Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review

Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review

Screening for atrial fibrillation (AF) has attracted considerable attention recently. Of special interest are patients with cardiac implantable electronic devices (CIEDs) that allow for recording episodes of atrial arrhythmias of various durations, including asymptomatic ones, in which case they are...

Full description

Bibliographic Details
Main Authors:	Tatiana V. Razina, Maria V. Serova, Denis A. Andreev, Yulia S. Sazonova, Anna G. Komarova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2023-05-01
Series:	Терапевтический архив
Subjects:	anticoagulant therapy subclinical atrial fibrillation atrial high-rate episodes cardiac implantable electronic devices
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/472054/125354

Similar Items

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
by: Ahmed AlTurki, et al.
Published: (2019-09-01)

Association between alcohol consumption and subclinical atrial fibrillation
by: Ga-In Yu, et al.
Published: (2023-09-01)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
by: Rachel M. Kaplan, et al.
Published: (2020-12-01)

Subclinical atrial fibrillation - what is the risk of stroke?
by: Jiri Plasek, et al.
Published: (2019-06-01)

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

The utilization of atrial sensing dipole in single lead implantable cardioverter defibrillator for detection of new‐onset atrial high‐rate episodes or subclinical atrial fibrillation: A systematic review and meta‐analysis
by: Xuanming Pung, et al.
Published: (2022-04-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

A pharmacotherapy of atrial fibrillation in subclinical thyrotoxicosis
by: R.F. Rakhmatullov, et al.
Published: (2021-09-01)

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patients?
by: E. I. Baranova, et al.
Published: (2022-07-01)

Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
by: Jacopo Francesco Imberti, et al.
Published: (2022-03-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
by: Wesley T. O'Neal, et al.
Published: (2018-03-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
by: Mary Bul, et al.
Published: (2023-06-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer
by: Li-Ying Yu, et al.
Published: (2022-06-01)

Impact of anxiety disorders on adherence to anticoagulant therapy in patients with atrial fibrillation
by: Anastasia V. Fomicheva, et al.
Published: (2022-10-01)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
by: Inmaculada Hernandez, et al.
Published: (2019-06-01)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
by: Amin A
Published: (2013-01-01)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
by: Celine Gallagher, et al.
Published: (2019-03-01)

Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation
by: Matthew E. Lapa, et al.
Published: (2023-11-01)

Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation
by: Daehoon Kim, et al.
Published: (2021-09-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
by: Celina M. Yong, et al.
Published: (2020-05-01)

DIAGNOSTICS OF ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE CARDIAC ELECTRONIC DEVICES: PREVALENCE AND RISK FACTORS
by: Yu. S. Sazonova, et al.
Published: (2017-12-01)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
by: Sylvie Perreault, et al.
Published: (2019-05-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images
by: Sung‐Hao Huang, et al.
Published: (2022-04-01)

Nonadherence to guideline-directed anticoagulations in atrial fibrillation in Iraq
by: Ameen M Mohammad, et al.
Published: (2021-01-01)

Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
by: Krishna N. Pundi, et al.
Published: (2021-12-01)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
by: Amgad Mentias, et al.
Published: (2021-09-01)

Oral anticoagulation use in non-valvular atrial fibrillation patients in rural setting
by: Camille Brod, et al.
Published: (2023-06-01)

Management of anticoagulation in atrial fibrillation patients in Italy: insight from the <i>Atrial Fibrillation-Survey on Anticoagulated Patients Register</i> (AF-START)
by: Daniela Poli, et al.
Published: (2023-06-01)

New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)

Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation
by: A. V. Fonyakin
Published: (2014-12-01)

A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
by: Andrei Viktorovich Fonyakin, et al.
Published: (2012-09-01)